Editorial
doi: 10.1056/NEJMe078116.
Epub 2007 Jun 5.
The record on rosiglitazone and the risk of myocardial infarction
- PMID: 17551162
- DOI: 10.1056/NEJMe078116
Item in Clipboard
Editorial
The record on rosiglitazone and the risk of myocardial infarction
N Engl J Med.
.
Free article
No abstract available
Comment on
-
Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.N Engl J Med. 2007 Jun 14;356(24):2457-71. doi: 10.1056/NEJMoa072761. Epub 2007 May 21. N Engl J Med. 2007. PMID: 17517853
-
Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.N Engl J Med. 2007 Jul 5;357(1):28-38. doi: 10.1056/NEJMoa073394. Epub 2007 Jun 5. N Engl J Med. 2007. PMID: 17551159 Clinical Trial.
Similar articles
-
Rosiglitazone and cardiovascular risk.N Engl J Med. 2007 Jun 14;356(24):2522-4. doi: 10.1056/NEJMe078099. Epub 2007 May 21. N Engl J Med. 2007. PMID: 17517854 No abstract available.
-
Rosiglitazone: a thunderstorm from scarce and fragile data.Ann Intern Med. 2007 Oct 16;147(8):585-7. doi: 10.7326/0003-4819-147-8-200710160-00013. Ann Intern Med. 2007. PMID: 17938398 No abstract available.
-
The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.N Engl J Med. 2013 Oct 3;369(14):1285-7. doi: 10.1056/NEJMp1309610. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992603 No abstract available.
-
Rosiglitazone and cardiovascular risk.Curr Atheroscler Rep. 2008 Oct;10(5):398-404. doi: 10.1007/s11883-008-0062-7. Curr Atheroscler Rep. 2008. PMID: 18706281 Review.
-
The rosiglitazone meta-analysis.Rev Cardiovasc Med. 2007 Spring;8(2):123-6. Rev Cardiovasc Med. 2007. PMID: 17603430 Review. No abstract available.
Cited by
-
Niacin: a re-emerging pharmaceutical for the treatment of dyslipidaemia.Br J Pharmacol. 2009 Sep;158(2):429-41. doi: 10.1111/j.1476-5381.2009.00349.x. Epub 2009 Jul 20. Br J Pharmacol. 2009. PMID: 19627285 Free PMC article. Review.
-
Rosiglitazone: a European regulatory perspective.Diabetologia. 2011 Feb;54(2):213-8. doi: 10.1007/s00125-010-1992-5. Epub 2010 Dec 14. Diabetologia. 2011. PMID: 21153629 No abstract available.
-
The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.PLoS One. 2014 Sep 30;9(9):e108722. doi: 10.1371/journal.pone.0108722. eCollection 2014. PLoS One. 2014. PMID: 25268242 Free PMC article.
-
Reporting bias in medical research - a narrative review.Trials. 2010 Apr 13;11:37. doi: 10.1186/1745-6215-11-37. Trials. 2010. PMID: 20388211 Free PMC article. Review.
-
DH9, a novel PPARγ agonist suppresses the proliferation of ADPKD epithelial cells: An association with an inhibition of β-catenin signaling.Invest New Drugs. 2010 Dec;28(6):783-90. doi: 10.1007/s10637-009-9313-x. Epub 2009 Sep 16. Invest New Drugs. 2010. PMID: 19756375
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
